Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL
Clinical trial NCT01449344 · UNKNOWN
Trial details
- NCT number
- NCT01449344
- Sponsor
- Prof. Dr. M. Dreyling (co-chairman)
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-09
- Primary completion
- 2018-12-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.